Bowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., . . . Njølstad, P. R. (2018). Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: An international cohort study. Lancet Diabetes Endocrinol.
Styl ChicagoBowman, Pamela, et al. "Effectiveness and Safety of Long-term Treatment With Sulfonylureas in Patients With Neonatal Diabetes Due to KCNJ11 Mutations: An International Cohort Study." Lancet Diabetes Endocrinol 2018.
Citace podle MLABowman, Pamela, et al. "Effectiveness and Safety of Long-term Treatment With Sulfonylureas in Patients With Neonatal Diabetes Due to KCNJ11 Mutations: An International Cohort Study." Lancet Diabetes Endocrinol 2018.